Jamal S Rana1,2,3,4, Jennifer Y Liu5, Howard H Moffet5, Marc Jaffe6, Andrew J Karter5. 1. Division of Cardiology, Kaiser Permanente Northern California, Oakland, CA, USA. jamal.s.rana@kp.org. 2. Department of Medicine, University of California San Francisco, San Francisco, CA, USA. jamal.s.rana@kp.org. 3. Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. jamal.s.rana@kp.org. 4. Division of Cardiology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA. jamal.s.rana@kp.org. 5. Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. 6. Division of Endocrinology, Kaiser Permanente Medical Center, South San Francisco, CA, USA.
Abstract
BACKGROUND: For more than a decade, the presence of diabetes has been considered a coronary heart disease (CHD) "risk equivalent". OBJECTIVE: The objective of this study was to revisit the concept of risk equivalence by comparing the risk of subsequent CHD events among individuals with or without history of diabetes or CHD in a large contemporary real-world cohort over a period of 10 years (2002 to 2011). DESIGN: Population-based prospective cohort analysis. PARTICIPANTS: We studied a cohort of 1,586,061 adult members (ages 30-90 years) of Kaiser Permanente Northern California, an integrated health care delivery system. MAIN MEASUREMENTS: We calculated hazard ratios (HRs) from Cox proportional hazard models for CHD among four fixed cohorts, defined by prevalent (baseline) risk group: no history of diabetes or CHD (None), prior CHD alone (CHD), diabetes alone (DM), and diabetes and prior CHD (DM + CHD). KEY RESULTS: We observed 80,012 new CHD events over the follow-up period (~10,980,800 person-years). After multivariable adjustment, the HRs (reference: None) for new CHD events were as follows: CHD alone, 2.8 (95% CI, 2.7-2.85); DM alone 1.7 (95% CI, 1.66-1.74); DM + CHD, 3.9 (95% CI, 3.8-4.0). Individuals with diabetes alone had significantly lower risk of CHD across all age and sex strata compared to those with CHD alone (12.2 versus 22.5 per 1000 person-years). The risk of future CHD for patients with a history of either DM or CHD was similar only among those with diabetes of long duration (≥10 years). CONCLUSIONS: Not all individuals with diabetes should be unconditionally assumed to be a risk equivalent of those with prior CHD.
BACKGROUND: For more than a decade, the presence of diabetes has been considered a coronary heart disease (CHD) "risk equivalent". OBJECTIVE: The objective of this study was to revisit the concept of risk equivalence by comparing the risk of subsequent CHD events among individuals with or without history of diabetes or CHD in a large contemporary real-world cohort over a period of 10 years (2002 to 2011). DESIGN: Population-based prospective cohort analysis. PARTICIPANTS: We studied a cohort of 1,586,061 adult members (ages 30-90 years) of Kaiser Permanente Northern California, an integrated health care delivery system. MAIN MEASUREMENTS: We calculated hazard ratios (HRs) from Cox proportional hazard models for CHD among four fixed cohorts, defined by prevalent (baseline) risk group: no history of diabetes or CHD (None), prior CHD alone (CHD), diabetes alone (DM), and diabetes and prior CHD (DM + CHD). KEY RESULTS: We observed 80,012 new CHD events over the follow-up period (~10,980,800 person-years). After multivariable adjustment, the HRs (reference: None) for new CHD events were as follows: CHD alone, 2.8 (95% CI, 2.7-2.85); DM alone 1.7 (95% CI, 1.66-1.74); DM + CHD, 3.9 (95% CI, 3.8-4.0). Individuals with diabetes alone had significantly lower risk of CHD across all age and sex strata compared to those with CHD alone (12.2 versus 22.5 per 1000 person-years). The risk of future CHD for patients with a history of either DM or CHD was similar only among those with diabetes of long duration (≥10 years). CONCLUSIONS: Not all individuals with diabetes should be unconditionally assumed to be a risk equivalent of those with prior CHD.
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Andrew J Karter; Assiamira Ferrara; Jennifer Y Liu; Howard H Moffet; Lynn M Ackerson; Joe V Selby Journal: JAMA Date: 2002-05-15 Impact factor: 56.272
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Shaista Malik; Matthew J Budoff; Ronit Katz; Roger S Blumenthal; Alain G Bertoni; Khurram Nasir; Moyses Szklo; R Graham Barr; Nathan D Wong Journal: Diabetes Care Date: 2011-08-15 Impact factor: 19.112
Authors: Andrew J Karter; Dean Schillinger; Alyce S Adams; Howard H Moffet; Jennifer Liu; Nancy E Adler; Alka M Kanaya Journal: Diabetes Care Date: 2012-10-15 Impact factor: 19.112
Authors: Favel L Mondesir; Todd M Brown; Paul Muntner; Raegan W Durant; April P Carson; Monika M Safford; Emily B Levitan Journal: Am Heart J Date: 2016-08-12 Impact factor: 4.749
Authors: David I Feldman; Javier Valero-Elizondo; Joseph A Salami; Jamal S Rana; Oluseye Ogunmoroti; Victor Okunrintemi; Chukwuemeka U Osondu; Erica S Spatz; Salim S Virani; Ron Blankstein; Michael J Blaha; Emir Veledar; Khurram Nasir Journal: Cardiovasc Endocrinol Metab Date: 2018-08-15
Authors: Sudipa Sarkar; Olusola A Orimoloye; Caitlin M Nass; Roger S Blumenthal; Seth S Martin Journal: J Gen Intern Med Date: 2019-08-14 Impact factor: 5.128
Authors: Nathan D Wong; Amber R Cordola Hsu; Alan Rozanski; Leslee J Shaw; Seamus P Whelton; Matthew J Budoff; Khurram Nasir; Michael D Miedema; John Rumberger; Michael J Blaha; Daniel S Berman Journal: Diabetes Care Date: 2020-08-17 Impact factor: 19.112
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: J Am Coll Cardiol Date: 2019-03-17 Impact factor: 24.094
Authors: Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian Journal: J Am Coll Cardiol Date: 2019-03-17 Impact factor: 24.094
Authors: Nathan D Wong; Ezra A Amsterdam; Christie Ballantyne; Amit Khera; Khurram Nasir; Peter P Toth Journal: Am J Cardiovasc Drugs Date: 2020-02 Impact factor: 3.571